| Analysis | Metabolite Name | Measured Value | Units | subject type |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+CL)- | 37924 | Peak area | Severe disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+CL)- | 59672 | Peak area | Severe disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+CL)- | 153115 | Peak area | Severe disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+CL)- | 163645 | Peak area | Severe disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+CL)- | 187933 | Peak area | Severe disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+CL)- | 217175 | Peak area | Healthy control |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+CL)- | 232380 | Peak area | Healthy control |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+CL)- | 243606 | Peak area | Mild disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+CL)- | 334847 | Peak area | Healthy control |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+CL)- | 354921 | Peak area | Healthy control |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+CL)- | 362615 | Peak area | Mild disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+CL)- | 373872 | Peak area | Mild disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+CL)- | 387832 | Peak area | Mild disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+CL)- | 411349 | Peak area | Healthy control |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+CL)- | 543742 | Peak area | Severe disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+CL)- | 675743 | Peak area | Mild disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+CL)- | 806861 | Peak area | Mild disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+CL)- | 1267171 | Peak area | Healthy control |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M-H)- | 21945 | Peak area | Severe disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M-H)- | 49641 | Peak area | Severe disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M-H)- | 63336 | Peak area | Severe disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M-H)- | 87551 | Peak area | Mild disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M-H)- | 90600 | Peak area | Severe disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M-H)- | 107406 | Peak area | Healthy control |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M-H)- | 124415 | Peak area | Healthy control |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M-H)- | 133291 | Peak area | Healthy control |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M-H)- | 138341 | Peak area | Mild disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M-H)- | 171319 | Peak area | Healthy control |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M-H)- | 171426 | Peak area | Severe disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M-H)- | 228712 | Peak area | Healthy control |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M-H)- | 252088 | Peak area | Mild disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M-H)- | 265010 | Peak area | Mild disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M-H)- | 311487 | Peak area | Severe disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M-H)- | 368124 | Peak area | Mild disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M-H)- | 488152 | Peak area | Mild disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M-H)- | 1460660 | Peak area | Healthy control |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+HCOO)- | 76848 | Peak area | Severe disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+HCOO)- | 83191 | Peak area | Severe disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+HCOO)- | 103597 | Peak area | Healthy control |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+HCOO)- | 112426 | Peak area | Severe disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+HCOO)- | 133039 | Peak area | Mild disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+HCOO)- | 153215 | Peak area | Mild disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+HCOO)- | 161501 | Peak area | Healthy control |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+HCOO)- | 196191 | Peak area | Healthy control |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+HCOO)- | 298591 | Peak area | Mild disease |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+HCOO)- | 677608 | Peak area | Healthy control |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+HCOO)- | Peak area | Healthy control | |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+HCOO)- | Peak area | Mild disease | |
| Reversed phase NEGATIVE ION MODE | URIDINE (CAS# 58-96-8); (M+HCOO)- | Peak area | Severe disease | |
| Reversed phase POSITIVE ION MODE | URIDINE (CAS# 58-96-8); (M+H)+ | 2484 | Peak area | Mild disease |
| Reversed phase POSITIVE ION MODE | URIDINE (CAS# 58-96-8); (M+H)+ | 10137 | Peak area | Healthy control |
| Reversed phase POSITIVE ION MODE | URIDINE (CAS# 58-96-8); (M+H)+ | 22836 | Peak area | Healthy control |
| Reversed phase POSITIVE ION MODE | URIDINE (CAS# 58-96-8); (M+H)+ | Peak area | Healthy control | |
| Reversed phase POSITIVE ION MODE | URIDINE (CAS# 58-96-8); (M+H)+ | Peak area | Mild disease | |
| Reversed phase POSITIVE ION MODE | URIDINE (CAS# 58-96-8); (M+H)+ | Peak area | Severe disease | |
| Reversed phase POSITIVE ION MODE | URIDINE (CAS# 58-96-8); (M+NA)+ | 15409 | Peak area | Healthy control |
| Reversed phase POSITIVE ION MODE | URIDINE (CAS# 58-96-8); (M+NA)+ | 16762 | Peak area | Mild disease |
| Reversed phase POSITIVE ION MODE | URIDINE (CAS# 58-96-8); (M+NA)+ | 18589 | Peak area | Severe disease |
| Reversed phase POSITIVE ION MODE | URIDINE (CAS# 58-96-8); (M+NA)+ | 24219 | Peak area | Severe disease |
| Reversed phase POSITIVE ION MODE | URIDINE (CAS# 58-96-8); (M+NA)+ | 26108 | Peak area | Mild disease |
| Reversed phase POSITIVE ION MODE | URIDINE (CAS# 58-96-8); (M+NA)+ | 26538 | Peak area | Healthy control |
| Reversed phase POSITIVE ION MODE | URIDINE (CAS# 58-96-8); (M+NA)+ | 27288 | Peak area | Severe disease |
| Reversed phase POSITIVE ION MODE | URIDINE (CAS# 58-96-8); (M+NA)+ | 31289 | Peak area | Mild disease |
| Reversed phase POSITIVE ION MODE | URIDINE (CAS# 58-96-8); (M+NA)+ | 37222 | Peak area | Mild disease |
| Reversed phase POSITIVE ION MODE | URIDINE (CAS# 58-96-8); (M+NA)+ | 38703 | Peak area | Severe disease |
| Reversed phase POSITIVE ION MODE | URIDINE (CAS# 58-96-8); (M+NA)+ | 42102 | Peak area | Healthy control |
| Reversed phase POSITIVE ION MODE | URIDINE (CAS# 58-96-8); (M+NA)+ | 48474 | Peak area | Mild disease |
| Reversed phase POSITIVE ION MODE | URIDINE (CAS# 58-96-8); (M+NA)+ | 58515 | Peak area | Healthy control |
| Reversed phase POSITIVE ION MODE | URIDINE (CAS# 58-96-8); (M+NA)+ | 58906 | Peak area | Mild disease |
| Reversed phase POSITIVE ION MODE | URIDINE (CAS# 58-96-8); (M+NA)+ | 147957 | Peak area | Healthy control |
| Reversed phase POSITIVE ION MODE | URIDINE (CAS# 58-96-8); (M+NA)+ | Peak area | Healthy control | |
| Reversed phase POSITIVE ION MODE | URIDINE (CAS# 58-96-8); (M+NA)+ | Peak area | Severe disease |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|